Legal

Smaller dose given by intradermal injection creates five-fold increase in total supply, FDA says.

Benefytt Technologies, Inc. would have to refund $100 million and stop misleading customers about coverage

HHS announces funding for programs in underserved, rural areas

Medicare drug prices, insulin costs affected by Inflation Reduction Act.

Medical Group Management Association wants six months’ notice before additional measures take effect

Sector still not at February 2020 levels and COVID-19 pandemic has lingering economic effects.

White House ramps up efforts to fight outbreak.

More people getting health coverage, but 26.4 million still don’t have it.

NBPAS added to Joint Commission’s list of accepted organizations for verifying provider credentials

21% think it’s OK to threaten public health officials over business closures

Attempts to steer more physicians into ACOs are part of the plan

American College of Physicians, AAFP backs Affordable Care Act subsidies, drug price negotiations for Medicare

More financial incentives for high-value services, greater data interoperability are needed to address problem

Study finds more depression, burnout as worries over childcare increase

Clues point to illegal kickbacks and schemes that put practitioners and patients at risk.

Alleged schemes include bribes, sham telehealth, unneeded heart and cancer testing.

Preliminary price forecasts could hint at industry trends for coming year.

Growth in remote work, cloud data storage present opportunities for hackers

State budget includes $100 million for new program.

Has health care price transparency actually arrived?

Murthy offers five areas of transformation.

New position paper has five recommendations for financing, nursing homes, family caregivers.

Study finds higher attrition rates among those with low incomes or from groups underrepresented in medicine

State regulations overruled to protect physicians’ clinical judgments.

Health agency leaders say tools are in place and deaths are preventable.

Federal, state laws put physicians in “impossible situation,” but they aim to work with legislators on policies.

FDA decision prompts praise from pharmacists for expanding treatment and equity around nation.

HHS to lead campaign with Attorney General and Federal Trade Commission for access and accurate information.

Stress created by COVID-19 pandemic strengthens need for “whole-person care,” they say